PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, USA.\', \'Institute for Disease Modeling, Global Health Division, Bill and Melinda Gates Foundation, Seattle, USA.\', \'Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, USA. jschiffe@fredhutch.org.\', \'Department of Medicine, University of Washington, Seattle, USA. jschiffe@fredhutch.org.\', \'Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA. jschiffe@fredhutch.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-91338-5
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34088959
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • Slight reduction in SARS-CoV-2 exposure viral load due to masking results in a significant reduction in transmission with widespread implementation.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all